The dawn of a new era for CRISPR patent strategy, multiplying mRNA patent wars, and 10x Genomics and NanoString’s cross-border spat were among the developments that defined the last 12 months
GenSight Biologics Provides Business and Financial Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GenSight Biologics is trading higher on the Paris Bourse on Wednesday, following an update on its operational and financial situation.In a press release, the biopharmaceutical company states that a.
Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of $27 billion by 2029.